Alyssa M Roberts
Overview
Explore the profile of Alyssa M Roberts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
7
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roberts A, West D, Stroebel B, Abuabara K
JAAD Int
. 2025 Jan;
18():174-176.
PMID: 39834711
No abstract available.
2.
West D, Roberts A, Stroebel B, Abuabara K
JAAD Int
. 2025 Jan;
18():151-153.
PMID: 39790866
No abstract available.
3.
Tau S, Chamberlin M, Yang H, Marotti J, Muskus P, Roberts A, et al.
Cancer Res
. 2025 Jan;
85(6):1145-1161.
PMID: 39777474
Despite adjuvant treatment with endocrine therapies, estrogen receptor-positive (ER+) breast cancers recur in a significant proportion of patients. Recurrences are attributable to clinically undetectable endocrine-tolerant persister cancer cells that retain...
4.
Tau S, Chamberlin M, Yang H, Marotti J, Roberts A, Carmichael M, et al.
bioRxiv
. 2024 Oct;
PMID: 39386444
Statement Of Significance: Endocrine-tolerant persister cancer cells that survive endocrine therapy can cause recurrent disease. Persister cells exhibit increased energetic dependence upon mitochondria for survival and tumor re-growth potential.
5.
Traphagen N, Schwartz G, Tau S, Roberts A, Jiang A, Hosford S, et al.
Clin Cancer Res
. 2023 Jul;
29(18):3717-3728.
PMID: 37439680
Purpose: Clinical evidence indicates that treatment with estrogens elicits anticancer effects in ∼30% of patients with advanced endocrine-resistant estrogen receptor α (ER)-positive breast cancer. Despite the proven efficacy of estrogen...
6.
Lantz M, Roberts A, Delgado D, Nichols R
J Neuroinflammation
. 2023 May;
20(1):129.
PMID: 37245024
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by accumulation of extracellular amyloid beta (Aβ) and intracellular neurofibrillary tangles, leading to chronic activation of astrocytes and microglia and...
7.
Traphagen N, Schwartz G, Tau S, Jiang A, Hosford S, Goen A, et al.
bioRxiv
. 2023 Mar;
PMID: 36993590
Purpose: Clinical evidence indicates that treatment with estrogens elicits anti-cancer effects in ∼30% of patients with advanced endocrine-resistant estrogen receptor alpha (ER)-positive breast cancer. Despite the proven efficacy of estrogen...